Immunomodulatory Research Peptides • Regenerative Research Peptides
ARA-290 – 10mg
$70.00$70.00
● In stock
ARA-290 (Cibinetide) is an 11-amino-acid synthetic peptide derived from the Helix B domain of erythropoietin (EPO), sequence QEQLERALNSS, CAS 1208243-50-8, MW ~1257.3. Supplied as a ≥99% HPLC-tested lyophilized powder — with a lot-specific third-party COA available before purchase — for in-vitro and laboratory research applications only. Research Use Only — not for human or veterinary use.
For laboratory research use only. Not for human or veterinary
consumption. This product should only be handled by qualified
professionals.
Product information
ARA-290, also referred to in the literature as Cibinetide, is an 11-amino-acid synthetic peptide corresponding to a sequence within the Helix B domain of the erythropoietin (EPO) molecule. Unlike full-length EPO, ARA-290 does not bind the classical EPO receptor and lacks erythropoietic activity; instead, it is studied in the research literature as a selective ligand of the innate repair receptor (IRR), a heteromeric complex composed of the EPO receptor and the common β-subunit (CD131). This product is supplied as a lyophilized powder in 10 mg vials, synthesized to research grade, and characterized by HPLC (purity) and LC-MS (identity), with a lot-specific third-party Certificate of Analysis available before purchase. It is intended exclusively for in-vitro laboratory research and analytical applications. In the research literature, ARA-290 is referenced as a tool compound used in the study of tissue-protective signaling, neuroregenerative research in cell-based models, and inflammatory pathway investigations related to the innate repair receptor complex.